Literature DB >> 15230527

Purification of paeoniflorin from Paeonia lactiflora Pall. by high-speed counter-current chromatography.

Feng Chen1, Hai-Tao Lu, Yue Jiang.   

Abstract

High-speed counter-current chromatography was successfully used for the first time for the preparative separation and purification of paeoniflorin from the Chinese medicinal plant Paeonia lactiflora Pall. using a two-phase solvent system composed of n-butanol-ethyl acetate-water (1:4:5, v/v) in a single run. From 160 mg of the crude sample containing 22.0% paeoniflorin, 33.2 mg of paeoniflorin was yielded at 98.2% purity as determined by HPLC analysis. The recovery of paeoniflorin was 94.3%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15230527     DOI: 10.1016/j.chroma.2004.04.023

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Herbaceous peony (Paeonia lactiflora Pall.) as an alternative source of oleanolic and ursolic acids.

Authors:  Chunhua Zhou; Ying Zhang; Yanle Sheng; Daqiu Zhao; Sansan Lv; Yue Hu; Jun Tao
Journal:  Int J Mol Sci       Date:  2011-01-18       Impact factor: 5.923

Review 2.  The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9.

Authors:  Aaron Hilliard; Patricia Mendonca; Tanya D Russell; Karam F A Soliman
Journal:  Nutrients       Date:  2020-11-27       Impact factor: 5.717

3.  Pharmacokinetic interaction between peimine and paeoniflorin in rats and its potential mechanism.

Authors:  Qiangjun Chen; Changlong Yin; Yongwei Li; Zhe Yang; Zongying Tian
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 4.  Counter-current chromatography for the separation of terpenoids: a comprehensive review with respect to the solvent systems employed.

Authors:  Krystyna Skalicka-Woźniak; Ian Garrard
Journal:  Phytochem Rev       Date:  2014-03-25       Impact factor: 5.374

5.  Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats.

Authors:  Jianyu Zhou; Linyuan Wang; Jingxia Wang; Chun Wang; Zhihui Yang; Chenglong Wang; Yingli Zhu; Jianjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.